ARK Investment Management Portfolio holdings
ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$7.94M |
| 2 |
NVIDIA
NVDA
|
+$7.13M |
| 3 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
+$6.22M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$6.17M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$5.77M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATHN
Athenahealth, Inc.
ATHN
|
+$4.09M |
| 2 |
Stratasys
SSYS
|
+$3.33M |
| 3 |
Illumina
ILMN
|
+$2.86M |
| 4 |
IBM
IBM
|
+$2.84M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$2.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.83% |
| 2 | Healthcare | 18.6% |
| 3 | Communication Services | 14.82% |
| 4 | Industrials | 12.56% |
| 5 | Consumer Discretionary | 12.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Amazon
AMZN
$2.5T
| $28.9M | 5.63% |
597,800
+166,440
| +39% | +$7.94M |
|
|
2
Stratasys
SSYS
$697M
| $28.8M | 5.6% |
1,233,679
-129,347
| -9% | -$3.33M |
|
|
ATHN
3
DELISTED
Athenahealth, Inc.
ATHN
| $27.3M | 5.32% |
194,366
-32,738
| -14% | -$4.09M |
|
4
Baidu
BIDU
$35.8B
| $18.4M | 3.58% |
102,901
+24,302
| +31% | +$4.4M |
|
|
5
NVIDIA
NVDA
$5.01T
| $18.3M | 3.57% |
5,070,760
+2,245,520
| +79% | +$7.13M |
|
|
6
Illumina
ILMN
$29.4B
| $18M | 3.51% |
106,716
-16,526
| -13% | -$2.86M |
|
|
TWTR
7
DELISTED
Twitter, Inc.
TWTR
| $16.5M | 3.21% |
921,982
+203,096
| +28% | +$3.46M |
|
|
JUNO
8
DELISTED
Juno Therapeutics, Inc.
JUNO
| $15M | 2.91% |
500,296
+252,029
| +102% | +$6.22M |
|
|
9
Alphabet (Google) Class C
GOOG
$3.9T
| $14.4M | 2.8% |
316,820
+134,840
| +74% | +$6.17M |
|
10
Protolabs
PRLB
$1.86B
| $14M | 2.72% |
207,577
+27,707
| +15% | +$1.67M |
|
11
Tesla
TSLA
$1.24T
| $13.7M | 2.66% |
567,540
+227,790
| +67% | +$5.01M |
|
|
BLUE
12
DELISTED
bluebird bio
BLUE
| $12.6M | 2.45% |
9,240
+2,858
| +45% | +$3.45M |
|
|
KITE
13
DELISTED
Kite Pharma, Inc.
KITE
| $11.7M | 2.27% |
112,645
+25,281
| +29% | +$2.06M |
|
|
SPLK
14
DELISTED
Splunk Inc
SPLK
| $11.5M | 2.23% |
201,612
+82,023
| +69% | +$5.1M |
|
|
XLNX
15
DELISTED
Xilinx Inc
XLNX
| $11.1M | 2.17% |
173,041
+91,460
| +112% | +$5.77M |
|
|
TWOU
16
DELISTED
2U Inc
TWOU
| $11M | 2.14% |
7,794
+1,697
| +28% | +$2.22M |
|
|
FMI
17
DELISTED
Foundation Medicine, Inc.
FMI
| $10.9M | 2.13% |
275,321
+16,413
| +6% | +$601K |
|
18
Meta Platforms (Facebook)
META
$1.51T
| $10.9M | 2.12% |
72,209
+14,221
| +25% | +$2.11M |
|
|
HDP
19
DELISTED
Hortonworks, Inc.
HDP
| $10.8M | 2.1% |
837,483
+46,391
| +6% | +$556K |
|
20
Salesforce
CRM
$134B
| $9.64M | 1.88% |
111,279
+30,792
| +38% | +$2.68M |
|
|
NVTA
21
DELISTED
Invitae Corporation
NVTA
| $9.39M | 1.83% |
982,170
+229,189
| +30% | +$2.26M |
|
22
Netflix
NFLX
$292B
| $9.37M | 1.82% |
627,150
+170,640
| +37% | +$2.63M |
|
23
Ionis Pharmaceuticals
IONS
$9.35B
| $9M | 1.75% |
176,991
+49,428
| +39% | +$2.3M |
|
24
Seres Therapeutics
MCRB
$48M
| $8.65M | 1.68% |
38,260
+6,764
| +21% | +$1.39M |
|
25
Editas Medicine
EDIT
$399M
| $8.56M | 1.67% |
510,187
+280,265
| +122% | +$5.05M |
|
Similar funds
ARK Investment Management's Q2 2017 Portfolio in Review
As of Q2 2017, ARK Investment Management held 110 positions worth $514M, up 48% from $347M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
ARK Investment Management deployed $120M of net new capital in Q2 2017, opening 6 new positions and adding to 94 existing holdings. Its largest new stake was Intuit: 17,139 shares worth $2.28M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Athenahealth, Inc., an estimated $4.09M trimmed.
- ARK Investment Management's largest Q2 2017 buy was Intuit: 17,139 shares worth $2.28M.
- ARK Investment Management added most to Amazon in Q2 2017, an estimated $7.94M increase.
- ARK Investment Management's biggest Q2 2017 reduction was Athenahealth, Inc., cutting an estimated $4.09M.
- ARK Investment Management fully exited Charles Schwab in Q2 2017, selling an estimated $2.55M.
- ARK Investment Management's ten largest holdings make up 39% of its $514M portfolio in Q2 2017.
- ARK Investment Management opened 6 new positions and closed 1 in Q2 2017.
- ARK Investment Management's portfolio value rose 48% quarter-over-quarter to $514M.
Based on ARK Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.